1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Neurostimulation Devices Market
2.2. Global Neurostimulation Devices Market, By Type, 2023 (US$ Million)
2.3. Global Neurostimulation Devices Market, By Therapeutic Areas, 2023 (US$ Million)
2.4. Global Neurostimulation Devices Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Neurostimulation Devices Market: Competitive Analysis
3.1. Market Positioning of Key Neurostimulation Devices Market Vendors
3.2. Strategies Adopted by Neurostimulation Devices Market Vendors
3.3. Key Industry Strategies
4. Neurostimulation Devices Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Neurostimulation Devices Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Spinal Cord Stimulators
5.3.2. Deep Brain Stimulators
5.3.3. Sacral Nerve Stimulators
5.3.4. Vagus Nerve Stimulators
5.3.5. Gastric Electric Stimulators

6. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Pain Management
6.3.2. Epilepsy
6.3.3. Essential Tremors
6.3.4. Urinary and Fecal Incontinence
6.3.5. Depression
6.3.6. Dystonia
6.3.7. Gastroparesis
6.3.8. Parkinson’s Disease
6.3.9. Others


7. North America Neurostimulation Devices Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
7.3. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
7.4.Neurostimulation Devices Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
7.4.1.1.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
7.4.1.2.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
7.4.1.3.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)

8. UK and European Union Neurostimulation Devices Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
8.3. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.4.Neurostimulation Devices Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
8.4.1.1.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
8.4.1.2.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
8.4.1.3.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
8.4.1.4.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
8.4.1.5.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
8.4.1.6.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)

9. Asia Pacific Neurostimulation Devices Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
9.3. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.4.Neurostimulation Devices Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
9.4.1.1.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
9.4.1.2.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
9.4.1.3.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
9.4.1.4.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
9.4.1.5.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
9.4.1.6.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)

10. Latin America Neurostimulation Devices Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
10.3. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.4.Neurostimulation Devices Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
10.4.1.1.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
10.4.1.2.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
10.4.1.3.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)

11. Middle East and Africa Neurostimulation Devices Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
11.3. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
11.4.Neurostimulation Devices Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
11.4.1.1.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
11.4.1.2.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Neurostimulation Devices Market: By Type, 2022-2032, USD (Million)
11.4.1.3.2. Neurostimulation Devices Market: By Therapeutic Areas, 2022-2032, USD (Million)

12. Company Profile
12.1. Medtronic
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. St. Jude Medical
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Boston Scientific Corporation
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Cyberonics
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Nevro Corp
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Cogentix Medical
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Neuronetics, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. IntraPace, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Codman & Shurtleff, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Other Notable Players
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives